Abstract
Objective
Study Design
Results
Conclusion
Implications statement
Keywords
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to ContraceptionReferences
- Induced abortions reported in Canada in 2019.CIHI, Ottawa, ON2021 (https://www.cihi.ca/sites/default/files/document/induced-abortions-reported-in-canada-in-2019-en.xlsx (Accessed April 25, 2020))
- First-trimester medical abortion practices in Canada: National survey.Canadian Fam Phys Med Fam Can. 2016; 62: e201-e2e8
- Abortion health services in Canada: results of a 2012 national survey.Canadian Fam Phys Med Fam Can. 2016; 62: e209-ee17
United Nations. Committee on the Elimination of Discrimination against Women: concluding observations on the combined eighth and ninth periodic reports of Canada. http://www.etoconsortium.org/nc/en/404/?tx_drblob_pi1%5BdownloadUid%5D=194, Accessed June 18, 2021: United Nations High Commissioner on Human Rights,; 2016.
Blaze Baum K. Health Canada eases restrictions on abortion pill Mifegymiso. The Globe & Mail. https://www.theglobeandmail.com/news/national/health-canada-eases-restrictions-on-abortion-pill-mifegymiso/article36860275/ Accessed September 28, 2021: Phillip Crawley; 2017.
- Canada Go Mifegymiso. Health Canada updates prescribing and dispensing information for Mifegymiso. Government of Canada, Ottawa2017 (editor2017)
- When there are no abortion laws: a case study of Canada.Best Pract Res Clin Obstet Gynaecol. 2020; 62: 49-62
Action Canada for Sexual Health and Rights. FAQ: the abortion pill mifegymiso. https://www.actioncanadashr.org/resources/factsheets-guidelines/2019-04-06-faq-abortion-pill-mifegymiso. (Accessed December 14, 2021). 2019.
- Medical abortion.J Obstet Gynaecol Can. 2016; 38: 366-389
- The perspective of rural physicians providing abortion in Canada: qualitative findings of the BC Abortion Providers Survey (BCAPS).PloS one. 2013; 8: e67070
- Barriers to rural induced abortion services in Canada: findings of the British Columbia Abortion Providers Survey (BCAPS).PloS one. 2013; 8: e67023
- Mail and internet surveys: the tailored design method.John Wiley and Sons Inc., New York, NY2000
- Development of a fraud detection plan in a survey of Canadian abortion providers.in: 49th Annual Meeting of the North American Primary Care Research Group (NAPCRG). 20. The Annals of Family Medicine, 2022: 2642
- RStudio: integrated development environment for R.RStudio, PBC, Boston, MA2021
- Nurses are key members of the abortion care team: why aren't schools of nursing teaching abortion Care?.Witness: Can J Crit Nurs Discourse. 2019; 1: 17-29
- Perspectives among Canadian physicians on factors influencing implementation of mifepristone medical abortion: a national qualitative study.Ann Fam Med. 2020; 18: 413-421
- The perspective of Canadian health care professionals on abortion service during the COVID-19 pandemic.Fam Pract. 2021; 38: i30-ii6
- Abortion safety and use with normally prescribed mifepristone in Canada.N Engl J Med. 2022; 386: 57-67
- Who can provide effective and safe termination of pregnancy care? A systematic review.BJOG. 2013; 120: 23-31
- Canada H Regulatory decision summary: MIFEGYMISO. Government of Canada, Ottawa, Canada2015 (editorp. copy on CART-GRAC website of the original government web page, now archived and not available)
- Pharmacist dispensing of the abortion pill in Canada: diffusion of Innovation meets integrated knowledge translation.Implement Sci. 2021; 16: 76
CART-GRAC (Contraception & Abortion Research Team-Groupe de recherche sur l'avortemont et la contraception). Canadian Abortion Providers Support-Communauté de pratique canadienne sur l'avortement (CAPS-CPCA) Community of Practice. In: CART-GRAC, editor. established 2017 ed. Vancouver, BC, Canada: University of British Columbia; 2017.
- Trends in medication abortion provision before and after the introduction of mifepristone: a study of the National Abortion Federation's Canadian member services.Contraception. 2020; 102: 119-121
- Abortion Surveillance — United States, 2019.MMWR Surveill Summaries. 2021; 70: 1-29
- Clinical follow-up compared with self-assessment of outcome after medical abortion: a multicentre, non-inferiority, randomised, controlled trial.Lancet. 2015; 385: 698-704
- Mifeprex risk evaluation and mitigation strategy (REMS).U.S. FDA, Silver Spring, MD2011 (FDA US, editor2957855)
- Mifepristone restrictions and primary care: breaking the cycle of stigma through a learning collaborative model in the United States.Contraception. 2021; 104: 24-28
- Could implementation of mifepristone address Canada’s urban-rural abortion access disparity: a mixed-methods implementation study protocol.BMJ Open. 2019; 9e028443
Kirkey S. Home abortion pill about to hit market in Canada, but has already garnered criticism. National Post. National ed. Toronto, Ontario, Canada: PostMedia; 2016.
- Effectiveness, safety and acceptability of medical abortion at home versus in the clinic: a systematic review and meta-analysis in response to COVID-19.BMJ Glob Health. 2020; 5: e003934
- Slow implementation of mifepristone medical termination of pregnancy in Quebec, Canada: a qualitative investigation.Eur J Cont Reprod Health Care. 2020; 25: 190-198
- Improving the quality of Web surveys: the Checklist for Reporting Results of Internet E-Surveys (CHERRIES).J Med Internet Res. 2004; 6: e34
Statistics Canada. Table 17-10-0135-01 Population estimates, July 1, by census metropolitan area and census agglomeration, 2016 boundaries. https://doi.org/10.25318/1710013501-eng. (Accessed September 15, 2021).
Article info
Publication history
Footnotes
☆Declaration of Competing Interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Funding: This work was supported by the Canadian Institutes of Health Research [PJT - 162201]. Dr. Norman is supported by a CIHR and Public Health Agency of Canada Chair in Applied Public Health Research (2014-2024, CPP-329455-107837).
